Table 5

Number and proportion of patients monitored and treated according to swallowing protocol

 Statewide aggregateQASC trial
ElementMonitoring and treatment for swallowingPreimplementation audit
(n=1062)
Postimplementation audit
(n=1082)
OR (95% CI)p ValueIntervention
group
(n=603)
Monitoring
Received a swallow screen within 24 h of admission to hospital453 (43%)562 (52%)1.57 (1.15 to 2.15)0.0047284 (47%)
Received a swallow assessment within 24 h of hospital admission404 (38%)418 (39%)1.01 (0.84 to 1.22)0.91330 (55%)
M1Received a swallow screen or a swallow assessment within 24 h of hospital admission733 (69%)814 (75%)1.38 (1.09 to 1.740.0068491 (81%)
M2Received a swallow screen or a swallow assessment before they were given food or drink (orally)605 (57%)736 (68%)1.60 (1.11 to 2.23)0.013135 (22%)
M3Received a swallow screen or a swallow assessment before they were given oral medications550 (52%)670 (62%)1.53 (1.10 to 2.13)0.011222 (37%)
Monitoring adherence*
Monitored according to protocol for swallow dysfunction454 (43%)565 (52%)1.50 (1.05 to 2.14)0.0365 (11%)
Treatment
Failed the swallow screen178 (17%)230 (21%)1.40 (1.05 to 1.86)0.0295 (16%)
T1Failed the swallow screen and received a swallowing assessment by a speech pathologist173 (97%)218 (95%)0.52 (0.17 to 1.57)0.2574 (78%)
Protocol adherence: monitored and treated
Monitored and treated according to the protocol for swallowing dysfunction450 (42%)556 (51%)1.47 (1.03 to 2.09)0.03362 (10%)
  • Day 1 indicates first 24 h since admission to hospital.

  • Statistically significant p values are shown in bold.

  • *Must meet all M1, M2 and M3 to be deemed as having been monitored according to protocol.

  • †Must meet all M1, M2, M3 and T1 to be deemed as having been monitored and treated according to protocol.

  • QASC, Quality in Acute Stroke Care.